Consumption Medicine Safety Supply Chain 
MMJ Recs
MARCH 16, 2024
Recent trends indicate a growing interest in alternative forms of consumption, such as edibles, topicals, and concentrates, in addition to traditional flower products. Regulations vary significantly by jurisdiction but typically encompass licensing requirements, product safety standards, and distribution protocols.
Veriheal
JUNE 1, 2023
However, more recent research detected safe levels of cannabinoids retained in the meat of the animals, such amounts considered safe for human consumption by global hemp regulatory frameworks. These research submissions may have left regulators skeptical about the safety of this relatively affordable, highly productive herb for livestock.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Veriheal
APRIL 14, 2022
The decree has been made public in an effort “to allow the creation of a sector ranging from cultivation to medicine based on cannabis for medical use in France.”. The development of a medically-authorized supply chain will be overseen by the National Agency for the Safety of Medicines and Health Products (ANSM).
MMJ Recs
FEBRUARY 23, 2024
The state’s dedication to patient well-being is reflected in its evolving regulations, ensuring safe and legal access to medical cannabis while promoting public health and safety. From the popularity of specific strains to evolving consumer preferences and consumption methods, the market analysis provides a comprehensive understanding.
Veriheal
AUGUST 31, 2020
These students showed knowledge and passion for the future of cannabis and posed revolutionary ideas rooted in their training across business, agriculture, biochemistry, public health, pharmacology, medicine, and liberal arts. . Essay: “Integrating Research and Medicine: Cannabis Related Treatment for Neurodegenerative Diseases”.
Veriheal
AUGUST 3, 2021
Mainly, the measure protects patient safety and amplifies product quality requirements, all the while entrusting the state’s Medical Marijuana Advisory Board to consider broadening the program’s list of qualifying medical conditions. Paul Schemel — claim that HB 1024 will also stimulate job creation.
Cannabis Law Report
AUGUST 19, 2019
This Client Alert sets out the current rules regarding the regulation of cannabis products and medicinal cannabis in the UK. To date, only one cannabis-based medicinal product, Sativex, (for the treatment of multiple sclerosis) has been licensed by the MHRA. i) a medicinal product, or. (ii) What substances are at issue?
Expert insights. Personalized for you.
105 
Let's personalize your content